The FibroScan Mini 430 is based on a transformative and non-invasive diagnostic technology called vibrationcontrolled transient elastography that has improved the management of patients with chronic liver diseases, which affect over 1 billion people worldwide. Light, ultra-mobile, rugged and battery-powered, the device has been designed to conduct health screening and prevention campaigns in remote areas without access to medical facilities.